References
- Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47.
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
- Briesacher BA, Andrade SE, Fouayzi H, et al. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–443.
- Lekkerkerker F, Kanis JA, Alsayed N, et al. Adherence to treatment of osteoporosis: a need for study. Osteoporos Int. 2007;18(10):1311–1317.
- Blackburn DF, Swidrovich J, Lemstra M. Non-adherence in type 2 diabetes: practical considerations for interpreting the literature. Patient Prefer Adherenc. 2013;7:183–189.
- Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314.
- Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med. 2005;165(20):2414–2419.
- Centers for Disease Control and Prevention (CDC) [Internet]. National Diabetes Statistics Report; 2014 [cited 2016 Nov]. Available from: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf
- Narayan KMV, Boyle JP, Geiss LS, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29(9):2114–2116.
- Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008;31(Suppl 2):S290–6.
- American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2017;40(Supplement 1):S1–S135.
- Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33(4):733–735.
- Peyrot M, Rubin RR, Kruger DF, et al. Correlates of insulin injection omission. Diabetes Care. 2010;33(2):240–245.
- Ascher-Svanum H, Lage MJ, Perez-Nieves M, et al. Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus. Diabetes Ther. 2014;5(1):225–242.
- Perez-Nieves M, Kabul S, Desai U, et al. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US. Curr Med Res Opin. 2016;32(4):669–680.
- Centers for Disease Control and Prevention (CDC) [Internet]. National Ambulatory Medical Care Survey: 2002 Summary; 2002 [cited 2016 Nov]. Available from: http://www.cdc.gov/nchs/data/ad/ad346.pdf
- Ha JF, Longnecker N. Doctor-patient communication: a review. Ochsner J. 2010;10(1):38–43.
- Ranjan P, Kumari A, Chakrawarty A. How can doctors improve their communication skills? J Clin Diagn Res. 2015;9(3):JE01–JE04.
- Yavuz DG, Ozcan S, Deyneli O. Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens. Patient Prefer Adherenc. 2015;9:1225–1231.
- Cooke CE, Lee HY, Tong YP, et al. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. Curr Med Res Opin. 2010;26(1):231–238.
- Wei W, Pan C, Xie L, et al. Real-world insulin treatment persistence among patients with type 2 diabetes. Endocr Pract. 2014;20(1):52–61.
- Peyrot M, Perez-Nieves M, Ivanova J, et al. Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multi-national survey. Curr Med Res Opin. 2017;33:1843–1851.
- Goold SD, Lipkin M. The doctor–patient relationship: challenges, opportunities, and strategies. J Gen Intern Med. 1999;14(Suppl 1):S26–S33.
- Travaline JM, Ruchinskas R, D’Alonzo JGE. Patient-physician communication: why and how. J Am Osteopath Assoc. 2005;105(1):13–18.
- Diette GB, Rand C. The contributing role of health-care communication to health disparities for minority patients with asthma. Chest. 2007;132(5Suppl):802s–809s.
- Arora NK. Interacting with cancer patients: the significance of physicians’ communication behavior. Soc Sci Med. 2003;57(5):791–806.
- Fentiman IS. Communication with older breast cancer patients. Breast J. 2007;13(4):406–409.
- Harmon G, Lefante J, Krousel-Wood M. Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications. Curr Opin Cardiol. 2006;21(4):310–315.
- Heisler M, Cole I, Weir D, et al. Does physician communication influence older patients’ diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol. 2007;62(12):1435–1442.
- Linetzky B, Jiang D, Funnell MM, et al. Exploring the role of the patient-physician relationship on insulin adherence and clinical outcomes in type 2 diabetes: insights from the MOSAIc study. J Diabetes. 2017;9(6):596–605.
- Diefenbach M, Turner G, Carpenter KM, et al. Cancer and patient-physician communication. J Health Commun. 2009;14(Suppl 1):57–65.
- Peyrot M, Rubin RR. Behavioral and psychosocial interventions in diabetes. Diabetes Care. 2007;30(10):2433.
- Perez-Nieves M, Ivanova JI, Hadjiyianni I, et al. Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey. Curr Med Res Opin. 2017;33(10):1833–1842.
- Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307.
- Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164(16):1749–1755.
- Alexander GC, Casalino LP, Tseng C-W, et al. Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med. 2004;19(8):856–860.
- NeedyMeds [Internet]. Diagnosis-Based Assistance Programs for diabetes; 2017 [cited 2017 Mar]. Available from: http://www.needymeds.org/copay_diseases.taf?_function=summary&disease_eng=diabetes
- American Diabetes Association [Internet]. Prescription Assistance; 2017 [cited 2017 Mar]. Available from: http://www.diabetes.org/living-with-diabetes/health-insurance/prescription-assistance.html
- National Institute of Diabetes and Digestive and Kidney Diseases [Internet]. Financial Help for Diabetes Care; 2017; [cited 2017 Mar]. Available from: https://www.niddk.nih.gov/health-information/diabetes/financial-help-diabetes-care
- Miller TA, DiMatteo MR. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes. 2013;6:421–426.
- American Diabetes Association [Internet]. Comprehensive Medical Evaluation and Assessment of Comorbidities; 2016 [cited 2017 Mar]. Available from: http://care.diabetesjournals.org/content/40/Supplement_1/S25.abstract